Many patients begin with phentermine due to its accessibility and low cost, then transition to a GLP-1 medication for long-term management
In contrast, the AIM-HIGH (Atherothrombosis intervention in metabolic syndrome with low HDL/high triglycerides: impact on global health outcomes) trial, which examined the incremental effect of extended-release nicotinic acid (1.5-2 g/day) on 3,414 patients who had established CVD and atherogenic dyslipidemia and were treated with simvastatin (+/- ezetimibe), provided disappointing results
Andreas Nygaard M, Gitte H, Sarah Juel P, et al
FDA has issued a warning letter to Zoll Medical Corporation following a 14-month inspection that uncovered significant manufacturing violations affecting critical medical devices including automated external defibrillators, MRI-compatible ventilators, and electrodes
Each hydro-cyclone processes 20 GPM